PAR 4.76% 22.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,857 Posts.
    lightbulb Created with Sketch. 1270
    Farmerbob alluded to this didn't he?

    Happy to see extra skills with fresh eyes take a crack.

    MPS deal no longer a stand-alone rather will be joined with OA for regional licensing. MPS1 (gag) wasn't going to be replicated on 5 year old kids in MPSVI given the nature of how the build up. The real merit of MPSV1 is safety on younger cohorts. Most ACL injuries happen with kids who are almost guaranteed to get early onset of OA. A possible silver lining
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.